CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial – Newswise (press release)
|
CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial
Newswise (press release) “It was not known whether CAR T-cells could be used to treat these high risk CLL patients,” said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. “Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … |
